Provenge Extends Life of Prostate Cancer Patients, Study Finds

Researchers found that Dendreon’s immunotherapy drug Provenge prolonged the lives of advanced prostate cancer patients by an average of 4.1 months compared to a placebo. This figure represents a 20 percent increase in life for the patient. Dendreon presented the results of their 512-patient Phase 3 IMPACT...

Microline PENTAX Acquires Starion Instruments

Two strong players in the surgical-instrument field have joined forces. Microline PENTAX, a leading manufacturer of reposable surgical instruments for laparoscopic procedures, has acquired California-based Starion Instruments, a developer of instruments to arrest bleeding during surgical procedures....

Isto Gets Go-Ahead for Clinical Study of NuQu

ISTO Technologies has received FDA approval to begin a Phase I clinical study for NuQu, an injectable formulation of juvenile cartilage cells designed to treat chronic back pain caused by degenerative disc disease. According to preclinical study data released last year, juvenile chondrocytes have the ability...

Thermo Fisher to Acquire Biolab

Thermo Fisher Scientific, a developer of analytical instruments and research products, has announced plans to acquire Biolab for $120 million. Biolab is Australia’s leading provider of laboratory supplies. The announcement comes after Thermo Fisher posted a 35 percent decline in net income for the first...

Major Milestone for Sunshine Heart

Sunshine Heart, a global company that develops cardiac assist devices, has successfully completed the first two implants of the company’s C-Pulse heart assist system under a 20-person clinical trial approved by the U.S. Food and Drug Administration. The devices were implanted by Dr. Benjamin Sun at the...

First Patient Successfully Treated With Algisyl-LVR Device

Symphony Medical, a developer of novel biopolymer technologies for cardiac disorders, has successfully used its flagship Algisyl-LVR technology to treat their first human patient. Over five million people in the U.S. suffer from chronic heart failure and mitral valve regurgitation. Algisyl-LVR is an...

[Company Profile] ScyFix Combats Age-Related Vision Loss

The idea of putting electrodes on one’s eyelids might cause many to cringe, but ScyFIX of Minnesota is turning this odd concept into a promising treatment for age-related vision loss. The company has spent eight years developing the first micro-current neuromodulation (MCN) device to treat degenerative eye...

Medtech Insight European Medical Device Conference: April 29-30, 2009

Join medical technology company investors and acquirers and secure your spot at the Leading Medical Device Strategic Partnering and Investment Event in Paris, France. Don’t miss this two-day conference, being held at the Marriott Rive Gauche Hotel & Conference Center in Paris on April 29th-30th. The...